Day: June 12, 2024

Financing extends Opthea’s cash runway through Phase 3 topline data readout for both pivotal trials of sozinibercept in wet AMD Phase 3 topline data readout accelerated for COAST to early Q2 calendar year 2025, and anticipated for ShORe in mid-calendar year 2025 MELBOURNE, Australia and PRINCETON, N.J., June 11, 2024 (GLOBE NEWSWIRE) — Opthea Limited (ASX/NASDAQ: OPT, “Opthea”, the “Company”), a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, including wet age-related macular degeneration (wet AMD), today announced that the Company is seeking to raise up to approximately A$227.3 million (US$150.0 million1) via an approximately A$10.0 million (US$6.6 million1) placement (“Placement”) and an approximately A$217.3 million (US$143.4 million1) Accelerated...

VANCOUVER, British Columbia, June 11, 2024 (GLOBE NEWSWIRE) — FIREWEED METALS CORP. (“Fireweed” or the “Company”) (TSXV: FWZ; OTCQX: FWEDF), is pleased to announce the results of voting at its annual general and special meeting of shareholders which was held on June 11, 2024, in Vancouver, BC (the “Meeting”). Full details of all the voting results for the 2024 Meeting are available on SEDAR+ at www.sedarplus.ca. A total of 78,544,062 common shares, representing 52.93% of the votes attached to all outstanding shares as at the record date for the Meeting, were represented at the Meeting. All of the matters submitted to the shareholders for approval as set out in the Company’s Notice of Meeting and Information Circular dated May 3, 2024, were approved by the requisite majority of votes cast at the Meeting. The nominees for directors...